Vistagen Therapeutics, Inc. (VTGN) › Capital ExpendituresVistagen Therapeutics, Inc. (VTGN) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2022: $02023: $528.0K2024: $0$02022Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$0-100.0%2023$528.0K—2022$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share